Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Closed
Phase 3
This trial is looking at switching treatment and then stopping treatment for chronic myeloid leukaemia (CML).
Recruitment start: 18 August 2014
Recruitment end: 31 May 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Jane Apperley
Novartis
Last reviewed: 25 Jun 2015
CRUK internal database number: 11990